Key result
N,N-Dimethyltryptamine improves post-transplant graft systolic pressure and contractility during reperfusion in rat hearts.
Why the study?
Ischemia-reperfusion injury during cold storage adversely affects donor heart graft function, and although N,N-dimethyltryptamine has shown cytoprotective effects under hypoxic and oxidative stress, its effects on graft recovery in heart transplantation needed evaluation.
Does N,N-dimethyltryptamine supplementation and perioperative treatment improve early post-transplant graft hemodynamic performance and attenuate ischemia-reperfusion injury in a rat heterotopic heart transplantation model?
Does N,N-dimethyltryptamine supplementation and perioperative treatment improve early post-transplant graft hemodynamic performance and attenuate ischemia-reperfusion injury in a rat heterotopic heart transplantation model?
In a preclinical rat heterotopic heart transplantation model, N,N-dimethyltryptamine administration improved early graft systolic contractility and diastolic relaxation at 60 minutes of reperfusion without altering coronary blood flow or systemic troponin levels.
Answers are grounded in this paper and cite their sources.
DMT may enhance early graft recovery in this rat transplant model; hypothesis-generating for human translation, requiring clinical trials.
Preserving donor organ viability during cold storage is critical for successful heart transplantation, as ischemia–reperfusion injury (IRI) adversely affects graft function. N, N-Dimethyltryptamine (DMT), an endogenous sigma-1 receptor ligand, has demonstrated cytoprotective effects under hypoxic and oxidative stress. This study evaluated the effects of DMT on graft recovery in a rat model of heterotopic heart transplantation. Hearts from male Lewis rats were preserved for 1 h at 4 °C in either Custodiol solution or Custodiol supplemented with DMT. Both donors and recipients in the treatment group also received DMT. After transplantation, graft function was assessed 60 min into reperfusion using preload-dependent pressure measurements, complemented by molecular and histological evaluations. DMT-treated grafts exhibited higher left ventricular systolic pressure, enhanced myocardial contractility and improved diastolic relaxation compared with controls. Gene expression analysis revealed significant modulation of Ddit3 , Hif1a and Vldlr , with trends in apoptotic and metabolic markers. A strong trend toward increased cleaved caspase-3 expression and significantly higher p62 immunohistochemical scores were observed, whereas cardiac troponin I and TNF-α levels remained unchanged. Overall, these findings indicate that DMT treatment improves early post-transplant graft contractile performance under the experimental conditions tested. The mechanisms underlying the observed functional improvement remain to be further elucidated.
No takes yet. Share an insight, caveat, or question.
Csonka et al. (2026) studied Heart transplantation ischemia-reperfusion injury (n=20). N,N-Dimethyltryptamine (DMT) vs. Custodiol solution alone without pharmacological treatment was evaluated on Left ventricular systolic pressure (LVSP) across increasing preload volumes at 60 minutes of reperfusion (p=0.0040). N,N-Dimethyltryptamine increased graft left ventricular systolic pressure and contractility after 60 minutes of reperfusion in rat heart transplants.
Synapse has enriched 10 related papers. Consider them for comparative context: